Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy

Maturitas

Volumn 32, Issue 2, 1999, Pages 77-86

  Björn, Inger ^a   Bäckström, Torbjörn ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Compliance; Estrogen; HRT

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE; NORETHISTERONE;

ARTICLE; BREAST DISEASE; DEPRESSION; FEMALE; FOLLOW UP; HEADACHE; HORMONE SUBSTITUTION; HUMAN; IRRITABILITY; LIBIDO; MENSTRUAL IRREGULARITY; ORAL DRUG ADMINISTRATION; PATIENT CARE; PATIENT COMPLIANCE; POSTMENOPAUSE; QUESTIONNAIRE; SIDE EFFECT; TRANSDERMAL DRUG ADMINISTRATION; WEIGHT GAIN;

ADULT; AGED; COHORT STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; POSTMENOPAUSE; QUESTIONNAIRES; SWEDEN; TREATMENT REFUSAL;

EID: 17344391805     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(99)00018-3     Document Type: Article

References (37)

1. Wiklund I., Karlberg J., Mattsson L.-Å. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: A double blind placebo-controlled study. Am J Obstet Gynecol. 168:1993;824-830.
2. Limouzine-Lamothe M.-A., Mairon N., Joyce C.R.B., Le Gal M. Quality of life after the menopause: Influence on hormonal replacement therapy. Am J Obstet Gynecol. 170:1994;618-624.
3. Eiken P., Nielsen S.P., Kolthoff N. Effect on bone mass after eight years of hormonal replacement therapy. Br J Obstet Gynaecol. 104(6):1997;702-707.
4. Paganini-Hill A., Henderson V.W. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol. 140:1994;256-261.
5. Paganini-Hill A. Oestrogen replacement therapy and Alzheimer's disease. Br J Obstet Gynaecol. 103(Suppl 13):1996;80-86.
6. Grodstein F., Stampfer M.J., Manson J.A.E., Colditz G.A., Willett W.C., Rosner B. et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. New Engl J Med. 335:1996;453-461.
7. National Opinion Poll Survey. The menopause revolution. How far have we come? Horsham: CIBA Pharmaceuticals, 1991.
8. Ryan P.J., Harrison R., Blake G.M., Fogelman I. Compliance with hormone replacement therapy (HRT) after screening for postmenopausal osteoporosis. Br J Obstet Gynaecol. 99:1992;325-328.
9. Wallace W.A., Price V.H., Elliot C.A., Mac Pherson M.B.A., Scott B.W. Hormone replacement therapy acceptability to Nottingham post-menopausal women with a risk factor for osteoporosis. J R Soc Med. 83:1990;669-701.
10. Dören H., Schneider H.P.G. Long term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women. Maturitas. 25:1996;99-105.
11. Dören M., Reuther G., Minne H.W., Schneider H.P.G. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women. Am J Obstet Gynecol. 173:1995;1446-1451.
12. Eiken P., Kolthoff N. Compliance with long-term oral hormonal replacement therapy. Maturitas. 22:1995;97-103.
13. Mattsson L.-Å., Stadberg E., Milsom I. Management of hormone replacement therapy; the Swedish experience. Eur J Obstet Gynecol Reprod Biol. 64:1996;3-5.
14. Hammarbäck S., Bäckström T., Holst J., v Schoulz B., Lyrenäs S. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy. Acta Obstet Gynecol Scand. 64:1985;393-397.
15. Cano A. Compliance to hormone replacement therapy in menopausal women controlled in a third level academic center. Maturitas. 20:1994;91-99.
16. Kirkham C., Hahn P.M., vanVugt D.A., Carmichael J.A., Reid R.L. A randomized, double-blind, placebo-controlled, cross-over trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapy. Obstet Gynecol. 87(1):1991;93-97.
17. Rozenberg S., Vandromme J., Kroll M., Pastijn A., Liebens F. Compliance to hormone replacement therapy. Int J Fertil Menopausal Study. 40(Suppl 1):1995;23-32.
18. Corzon S.L. A practical guide to prescribing estrogen replacement therapy. Int J Fertil Menopausal Study. 40:1995;229-247.
19. Dören M., Schneider H.P.G. The impact of different HRT regimens on compliance. Int J Fertil Menopausal Study. 41:1996;29-39.
20. Stumpf P.G., Trolice M.P. Compliance problems with hormone replacement therapy. Obstet Gynecol Clin North Am. 21:1994;219-229.
21. Pitkin J. HRT: Are we achieving compliance? Eur Menopause J. 2(Suppl 4):1995;36-40.
22. Mattsson L.-Å. What do women want? Br J Obstet Gynaecol. 103(Suppl 13):1996;104-107.
23. Isaacs A.J., Britton A.R., Mc Pherson K. Utilization of hormone replacement therapy by women doctors. Br Med J. 311:1995;1399-1401.
24. Andersson K., Mattson L.-Å., Milsom I. Use of hormone replacement therapy. Lancet. 348:1996;1521.
25. Nachtigall L.E. Enhancing patient compliance with hormone replacement therapy at menopause. Obstet Gynecol. 75(Suppl 4):1990;77-80.
26. Statistiska Centralbyrån (SCB). Yrkesklassificeringar i FoB 85 enligt Nordisk yrkesklassificering (NYK) och Socioekonomisk indelning (SEI); MIS 1989:5. Stockholm, Sweden: Statistics Sweden, 1995.
27. Dalton K. The premenstrual syndrome and progesterone therapy. 1984;Heineman, London.
28. Hammarbäck S., Bäckström T., MacGibbon-Taylor B. Diagnosis of premenstrual tension syndrome: description and evaluation of a procedure for diagnosis and differential diagnosis. J Psychsom Obstet Gynaecol. 10:1989;25-42.
29. von Schoulz B. Climacteric complaints as influenced by progesterons. Maturitas. 8:1986;107-112.
30. Sherwin B.B. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab. 72:1991;336-343.
31. Bäckström T. Central nervous system effects, mood and cognitive function related to menopause and hormone replacement therapy. Sjöberg I., Berg G., Hammar M., Mattson L.Å. The climacteric and its treatment. 1997;75-86 Parthenon, Lancashire, UK.
32. Fombonne E. Increased rates of depression: update of epidemiological findings and analytical problems. Acta Psychiatr Scand. 90:1994;145-156.
33. Ravnikar A.V. Compliance with hormone replacement therapy: are women receiving the full impact of hormone replacement therapy preventive health benefits? Women's Health Issues. 2:1992;75-81.
34. Coope J., Marsh J. Can we improve compliance with long-term HRT? Maturitas. 15:1992;151-158.
35. Fallsberg M. Reflections on medicines and medication - a qualitative analysis among people on long-term drug regimens. 1991;Department of Education and Psychology, Linköping University, Linköping.
36. Scherman M.H. Att vägra vara sjuk. En longitudinell studie av förhållningssätt till astma/allergi. 1995;Acta Universitatis Gothoburgenses, Göteborg.
37. Rössner S. Det väger allt tyngre att vara svensk. Lakartidningen. 89(25):1992;2282-2284.